| \begin{table}[ht!] \begin{adjustbox}{max width=.8\textwidth} \begin{threeparttable} \caption{Impacts on Malaria Treatment Outcomes - Heterogeneity by Predicted Malaria Risk} \label{mal_tmt_het_nl} {\begin{tabular}{l*{6}{C{0.12\linewidth}}} \toprule \toprule & (1) & (2) & (3) & (4) & (5) \\ & & \multicolumn{2}{c}{Any Malaria Treatment} & \multicolumn{2}{c}{Severe Malaria Treatment} \\ \cmidrule(lr){3-4} \cmidrule(lr){5-6} \\ & Used Voucher& Prescribed& Purchased& Prescribed& Purchased \\ \toprule |
| $\delta_{PH}$: Patient Voucher $\times$ High Risk& 0.34\sym{***}& 0.035 & 0.11\sym{***}& -0.056\sym{*} & -0.023 \\ |
| & (0.040) & (0.037) & (0.039) & (0.031) & (0.032) \\ |
| $\delta_{DH}$: Doctor Voucher $\times$ High Risk& 0.32\sym{***}& 0.032 & 0.082\sym{**} & -0.12\sym{***}& -0.12\sym{***}\\ |
| & (0.038) & (0.033) & (0.036) & (0.034) & (0.032) \\ |
| $\delta_{PL}$: Patient Voucher $\times$ Low Risk& 0.36\sym{***}& 0.090\sym{**} & 0.18\sym{***}& -0.019 & -0.012 \\ |
| & (0.041) & (0.036) & (0.040) & (0.027) & (0.028) \\ |
| $\delta_{DL}$: Doctor Voucher $\times$ Low Risk& 0.20\sym{***}& 0.00094 & 0.079\sym{**} & -0.0013 & 0.0066 \\ |
| & (0.031) & (0.035) & (0.033) & (0.029) & (0.024) \\ |
| $\theta$: High Malaria Risk& -0.054 & 0.061 & 0.054 & 0.096\sym{**} & 0.078\sym{*} \\ |
| & (0.041) & (0.045) & (0.049) & (0.049) & (0.046) \\ |
| \emph{P-values and theory-driven tests}& & & & & \\ |
| \enspace $\delta_{PH}=\delta_{DH}$& 0.727 & 0.932 & 0.413 & 0.121 &0.012\sym{**} \\ |
| \enspace Test for mechanism:& GC/DD & -- & -- & DD & DD \\ |
| \enspace Significant evidence of mechanism:& No & -- & -- & No & No \\ |
| & & & & & \\ |
| \enspace $\delta_{PL}=\delta_{DL}$&0.000\sym{***} &0.016\sym{**} &0.011\sym{**} & 0.615 & 0.554 \\ |
| \enspace Test for mechanism:& GC/PD & PD & PD & -- & -- \\ |
| \enspace Significant evidence of mechanism:& Yes & Yes & Yes & -- & -- \\ |
| & & & & & \\ |
| Mean (Control, Low Risk)& 0.000 & 0.486 & 0.329 & 0.154 & 0.116 \\ |
| N & 2055 & 2053 & 2053 & 2053 & 2053 \\ |
| \hline \end{tabular} } \begin{tablenotes}[flushleft] \small \item \emph{Notes}: Robust standard errors clustered at the clinic level in parentheses. All regressions control for clinic visit date fixed effects. Controls include number of symptoms, symptom dummies, duration of illness (topcoded at the 99th percentile), patient age, a dummy for patients under 5, patient gender, dummy to identify pregnant patients, a dummy to identify whether the patient (versus a caregiver) answered the survey, the gender of the survey respondent, an ethnicity (Bambara) dummy, a dummy for French speaking respondents, a dummy for literate respondents, a dummy for respondents with a primary education or less. Missing values are recoded to the sample mean. GC, PD, and DD indicate tests of gatekeeping costs, patient-driven, and doctor-driven demand respectively. *, **, and *** denote statistical significance at the 10, 5, and 1 percent levels respectively. \end{tablenotes} \end{threeparttable} \end{adjustbox} \end{table} |
|
|
